April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Meta Analysis of One Versus Two-Site Phaco-Trabeculectomy
G. A. Gdih; D. Yuen; P. Yan; L. Sheng; Y.-P. Jin; Y. M. Buys
Author Affiliations & Notes
  • G. A. Gdih
    Ophthalmology and Vision Sciences,
    University of Toronto, Toronto, Ontario, Canada
  • D. Yuen
    Ophthalmology and Vision Sciences,
    University of Toronto, Toronto, Ontario, Canada
  • P. Yan
    Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
  • L. Sheng
    University of Toronto, Toronto, Ontario, Canada
  • Y.-P. Jin
    Ophthalmology and Vision Sciences,
    Dalla Lana School of Public Health,
    University of Toronto, Toronto, Ontario, Canada
  • Y. M. Buys
    Ophthalmology and Vision Sciences,
    University of Toronto, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships  G.A. Gdih, None; D. Yuen, None; P. Yan, None; L. Sheng, None; Y.-P. Jin, None; Y.M. Buys, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 613. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Meta Analysis of One Versus Two-Site Phaco-Trabeculectomy
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      G. A. Gdih, D. Yuen, P. Yan, L. Sheng, Y.-P. Jin, Y. M. Buys; Meta Analysis of One Versus Two-Site Phaco-Trabeculectomy. Invest. Ophthalmol. Vis. Sci. 2010;51(13):613.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : The last systematic review of one- vs two-site phacotrabeculectomy included 5 prospective and 1 retrospective study and concluded there was weak evidence that two-site phacotrabeculectomy provides 1-2 mmHg lower IOP than one-site surgery. Since this review there have been further publications on this topic stimulating this meta-analysis.

Methods: : This study was conducted according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement. RCTs comparing one- versus two-site phacotrabeculectomy were searched up to the end of August 2009 using MEDLINE and the Cochrane Registry with the keyword phacotrabeculectomy. Inclusion criteria were prospective RCTs, minimum 12 months follow-up and English language. Two reviewers independently reviewed each article using standardized data collection sheets. Any discrepancies were resolved by consensus. Quality of the trials was assessed using the Cochrane collaboration’s tool of assessing risk of bias. The main outcome measure was IOP and secondary outcomes included glaucoma medications, visual acuity, complications and surgical time. The pooled reduction for each variable at each time point was computed if study results were homogeneious as indicated by the heterogeneity test.

Results: : The initial search yielded 167 articles. The abstracts were reviewed and 18 articles with potentially relevant trials were reviewed in entirety. 6 were excluded and the remaining 12 included in the meta-analysis. There was no significant difference in the amount of IOP reduction between one- and two-site phacotrabeculectomy. The IOP decrease from baseline in mmHg (95% CI) was: 7.85 (6.76-8.92) vs 5.83 (4.72-6.94) at one month; 8.03 (7.38-8.67) vs 7.03 (6.35-7.71) at 3 months; 7.78 (7.14-8.42) vs 6.75 (6.04-7.46) at 6 months; 6.44 (5.47-7.41) vs 6.68 (5.56-7.81) at 12 months; 7.17 (6.45-7.89) vs 6.56 (5.77-7.35) at 24 months and 7.76 (7.02-8.49) vs 7.14 (6.36-7.92) at 36 months for one- vs two-site respectively. There was no significant difference in glaucoma medications or VA.

Conclusions: : This meta-analysis of 12 RCTs comparing one- versus two-site phacotrabeculectomy found no significant difference in reduction of IOP, glaucoma medications, and change in visual acuity from baseline. There was however a tendency for a greater IOP reduction for one-site surgery.

Keywords: clinical (human) or epidemiologic studies: outcomes/complications • intraocular pressure • treatment outcomes of cataract surgery 
© 2010, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept